Research Article
Tumor-Derived Exosomal miR-620 as a Diagnostic Biomarker in Non-Small-Cell Lung Cancer
Table 2
Response to the first chemotherapy in serum exosomal miR-620.
| ||||||||||||||||||||||||||||||||||||||||
CR: complete response, PR: partial response, SD; stable disease, PD: progressive disease, RR: response rate; DCR: disease control rate. | ||||||||||||||||||||||||||||||||||||||||